CLINICAL_TRIALS
trial_result
· 2017-09-27
Clinical Trial Update: Seroquel in the Treatment of Dysphoric Hypomania in Bipolar II [Phase 4]
Summary
Phase 4 trial evaluating Seroquel for dysphoric hypomania in Bipolar II Disorder has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Stanford University | Conditions: Bipolar II Disorder | Phase 4 | Status: COMPLETED | Results posted: 2017-09-27